|
In this Expert Commentary, Paul Ruest PhD interviews Dr Robert Giugliano regarding the process and choices associated with selecting an antithrombotic therapy for the patient with non-ST elevation myocardial infarction (NSTEMI). Dr Giugliano will describe in detail the evidence supporting guideline recommendations and discuss risk stratification, available agents, and the rationale behind selecting these agents for treating this patient population. |